Cited by

• The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum.

  Zivanovic O, Sima CS, Iasonos A, Hoskins WJ, Pingle PR, Leitao MM Jr, Sonoda Y, Abu-Rustum NR, Barakat RR, Chi DS. Zivanovic O, et al. Gynecol Oncol. 2010 Mar;116(3):351-7. doi: 10.1016/j.ygyno.2009.11.022. Gynecol Oncol. 2010. PMID: 20022092 Free PMC article.
• Residual Disease Threshold After Primary Surgical Treatment for Advanced Epithelial Ovarian Cancer, Part 1: A Systematic Review and Network Meta-Analysis.

  Bryant A, Johnson E, Grayling M, Hiu S, Elattar A, Gajjar K, Craig D, Vale L, Naik R. Bryant A, et al. Am J Ther. 2023 Jan-Feb 01;30(1):e36-e55. doi: 10.1097/MJT.0000000000001584. Epub 2022 Dec 20. Am J Ther. 2023. PMID: 36608071 Free PMC article.
• Ultra-radical (extensive) surgery versus standard surgery for the primary cytoreduction of advanced epithelial ovarian cancer.

  Hiu S, Bryant A, Gajjar K, Kunonga PT, Naik R. Hiu S, et al. Cochrane Database Syst Rev. 2022 Aug 30;8(8):CD007697. doi: 10.1002/14651858.CD007697.pub3. Cochrane Database Syst Rev. 2022. PMID: 36041232 Free PMC article.
• Patterns of Treatment and Outcomes in Epithelial Ovarian Cancer: A Retrospective North Indian Single-Institution Experience.

  Meena RK, Syed NA, Sheikh ZA, Guru FR, Mir MH, Banday SZ, Mp AK, Parveen S, Dar NA, Bhat GM. Meena RK, et al. JCO Glob Oncol. 2022 Nov;8:e2200032. doi: 10.1200/GO.22.00032. JCO Glob Oncol. 2022. PMID: 36332174 Free PMC article.
• Overexpression of Class III β-tubulin, Sox2, and nuclear Survivin is predictive of taxane resistance in patients with stage III ovarian epithelial cancer.

  Du J, Li B, Fang Y, Liu Y, Wang Y, Li J, Zhou W, Wang X. Du J, et al. BMC Cancer. 2015 Jul 23;15:536. doi: 10.1186/s12885-015-1553-x. BMC Cancer. 2015. PMID: 26198101 Free PMC article.